← All organizations
TGen Drug Development
Academic/HospitalWebsite ↗
Also known as: TGen Clinical Research Service at Scottsdale Healthcare | TGen Clinical Research Services at Scottsdale Healthcare | TGEN Clinical Research Services at Scottsdale Healthcare | Translational Genomics Research Institute | Translational Genomics Research Institute (TGen) An Affiliate of City of Hope
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2007Last known activity
Dec 31, 2023
Timeline
2000s
- Jan 1, 2003
TGen Drug Development— Founded
Drugs by trial phase (19 distinct, 17 trials)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT06076837CollaboratorPhase 1Dec 31, 2023
- NCT04732247CollaboratorPhase 2Jul 1, 2021
- NCT04098250CollaboratorPhase 2Oct 1, 2019
- NCT03697239CollaboratorPhase 1/Phase 2Jun 30, 2019
- NCT03908333CollaboratorPhase 1/Phase 2May 1, 2019
- NCT03797443CollaboratorPhase 1/Phase 2Jan 1, 2019
- NCT03649321CollaboratorPhase 1/Phase 2Nov 30, 2018
- NCT03415854CollaboratorPhase 2Jan 31, 2018
- NCT03331562Lead sponsorPhase 2Dec 27, 2017
- NCT03331562Study directorPhase 2Dec 27, 2017
- NCT03410030CollaboratorPhase 1/Phase 2Dec 15, 2017
- NCT01298011Overall official - principal investigatorPhase 2May 1, 2011
- NCT00455052Overall official - principal investigatorPhase 1Mar 1, 2011
- NCT01313065Overall official - principal investigatorPhase 1Jan 1, 2011
- NCT01415297Overall official - principal investigatorPhase 1Oct 1, 2009
Details
- Founded
- Phoenix, AZ, US Jan 1, 2003
- Last known activity
- Dec 31, 2023